Abstract | OBJECTIVE: DATA SOURCES: A MEDLINE search of the English-language literature from 1992 to January 1997 was conducting using the key terms Tritec, ranitidine, and bismuth. References of articles pertaining to treatment of duodenal ulcer or HP were extensively searched for relevant sources. DATA EXTRACTION: All articles pertaining to ranitidine bismuth citrate were considered for inclusion, with emphasis placed on randomized, double-blind trials. Priority was placed on data pertaining to regimens that are currently approved by the Food and Drug Administration for the treatment of duodenal ulcer in conjunction with HP. DATA SYNTHESIS: CONCLUSIONS:
|
Authors | T G Vondracek |
Journal | The Annals of pharmacotherapy
(Ann Pharmacother)
Vol. 32
Issue 6
Pg. 672-9
(Jun 1998)
ISSN: 1060-0280 [Print] United States |
PMID | 9640487
(Publication Type: Journal Article, Review)
|
Chemical References |
- Anti-Ulcer Agents
- Ranitidine
- Bismuth
|
Topics |
- Anti-Ulcer Agents
(administration & dosage, adverse effects, pharmacokinetics, pharmacology)
- Bismuth
(administration & dosage, adverse effects, pharmacokinetics, pharmacology)
- Clinical Trials as Topic
- Drug Interactions
- Duodenal Ulcer
(drug therapy, microbiology)
- Formularies as Topic
- Helicobacter Infections
(drug therapy)
- Helicobacter pylori
- Humans
- Ranitidine
(administration & dosage, adverse effects, pharmacokinetics, pharmacology)
|